Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
CVRx, a Nasdaq-listed medical device company specializing in neuromodulation therapies for cardiovascular diseases, announced the nomination of Michael Dale to its board. Dale brings extensive leadership experience from the medical device sector, including roles at Abbott and as CEO of Axogen. His addition aims to bolster CVRx's commercial growth a…
FutureFuel Corp., a manufacturer of custom and performance chemicals and biofuels, will release its financial results for Q1 2026 on May 11, 2026, after market close. The announcement is a routine earnings release notification without additional operational updates.
Magnite, the largest independent sell-side advertising platform, announced the retirement of CFO David Day, who will remain through September 2026 and then as special advisor through May 2027. The company has initiated a search for his successor, while reaffirming its 2026 financial guidance. Day has been instrumental in key mergers and growth over…
The White House on Monday issued a presidential determination invoking the Defense Production Act to accelerate expansion of natural gas transmission, processing, storage and liquefied natural gas facilities across the United States. The memorandum, addressed to the Secretary of Energy, designates a broad set of gas and LNG assets as essential to n…
Jorge Andres Cedron, Chief Legal Officer of Orthofix Medical Inc. (NASDAQ:OFIX), sold 3,743 shares on April 16, 2026 for $47,985 at $12.82 per share to meet tax withholding obligations related to restricted stock unit settlement. The sale was carried out under a pre-authorized sell-to-cover program approved by the Compensation and Talent Developmen…
Cognition Therapeutics President and CEO Lisa Ricciardi bought $10,092 of company stock on April 16, 2026, increasing her direct holdings to 1,715,851 shares. The transaction coincides with the company reporting a reduced net loss for 2025 and plans to engage the FDA on a registrational pathway for zervimesine following positive Phase 2 SHIMMER res…
John Brendan Doyle, chief financial officer of Cognition Therapeutics Inc. (NASDAQ: CGTX), purchased 10,000 shares of the company on April 16, 2026, at $1.13 per share. The transaction increased his direct holdings to 627,509 shares. The buy coincides with strong recent stock performance and company updates showing narrower losses and a plan to pur…
Anthony Caggiano, Chief Medical Officer of Cognition Therapeutics Inc. (NASDAQ: CGTX), bought 10,000 shares on April 16, 2026, paying $1.11 per share for a total of $11,100. The transaction leaves him with 874,906 shares on a direct basis. The purchase comes amid notable share-price momentum and follows the company’s 2025 results, which showed a re…
President Donald Trump on Monday signed a presidential determination invoking section 303 of the Defense Production Act to accelerate the development, manufacturing and deployment of large-scale energy infrastructure. The memorandum, addressed to the Secretary of Energy, cites an earlier executive order that declared a national energy emergency and…
Exzeo Group CEO Paresh Patel purchased 2,000 shares of company stock on April 17, 2026, for $33,880. The deal increases his direct holdings to 1,618,013 shares. The company reported fourth-quarter and full-year 2025 results in line with analyst expectations, with diluted EPS of $0.25 and quarterly revenue of $53.32 million. Exzeo’s shares rose afte…
Belite Bio's Chief Scientific Officer, Nathan L. Mata, sold 1,000 American depositary shares on April 16, 2026, totaling roughly $160,380. The transactions were carried out under a Rule 10b5-1 trading plan. The company is progressing toward a New Drug Application submission for tinlarebant following positive Phase 3 DRAGON results, prompting severa…
James Mulay, a director at CG Oncology, disposed of 15,600 common shares on April 17, 2026, through a pre-arranged Rule 10b5-1 plan. The sale, executed at a weighted average price of $73.01, generated proceeds of $1,138,956. Mulay had earlier acquired the same shares by exercising vested director stock options at $36.63 per share. The transaction l…
Nathan L. Mata, chief scientific officer of Belite Bio, sold 1,000 American depositary shares on April 17, 2026, generating $161,629 under a Rule 10b5-1 plan adopted December 10, 2025. The transaction coincides with a period of significant stock appreciation and a string of favorable clinical and analyst developments tied to tinlarebant for Stargar…
Nektar shares surged after clinical proof-of-concept and clear late-stage execution on REZPEG. The market is pricing a premium, but the combination of limited float, improving technicals, and near-term development catalysts make this a strong buy for a disciplined long with a 180-trading-day horizon. Key risks include ongoing securities litigation,…
Wintrust Financial Corporation announced record net income of $227.4 million for Q1 2026, marking a fifth consecutive quarter of record earnings. The company experienced strong loan growth of $1.0 billion and robust deposit growth of $1.2 billion, coupled with prudent expense management and stable credit quality. Net interest margin improved slight…
Spectral AI, a Nasdaq-listed AI medical diagnostics company specializing in wound care, has announced its 2026 Annual Meeting of Stockholders to be held on May 29, 2026. The meeting will allow stockholders to vote in person or virtually, with important details provided in the Definitive Proxy Statement filed with the SEC. Spectral AI is focused on …
Archrock, an energy infrastructure company specializing in natural gas compression, announced it will release its first quarter 2026 financial results before hosting a conference call on May 6, 2026. The event will provide investors updates on the company's performance and operating results.
Powell Industries announced it will release its fiscal 2026 second quarter results on May 4, 2026, after market close. The company will host a conference call on May 5, 2026, to discuss the earnings. Powell, specializing in custom engineered electrical energy management solutions, serves major industrial sectors including utilities, oil and gas, pe…
Fabrinet announced it will release its financial results for the third quarter of fiscal year 2026 on May 4, 2026, followed by a conference call and webcast. The company, a leading provider of advanced optical packaging and precision manufacturing services, caters to OEMs of complex products across various sectors including optical communications, …
Kingstone Companies, a regional property and casualty insurance holding company, announced an extension of President and CEO Meryl Golden's employment agreement through January 10, 2029. The Board reaffirmed confidence in Golden’s leadership following a return to record profitability and outlined plans for expansion into California and other states…
Scorpio Tankers Inc. has reached agreements to divest six vessels built in 2014 for a combined $300 million. The package includes three LR2 product tankers sold together for $195 million and three MR product tankers sold for $105 million. The transactions are expected to close within the second quarter of 2026. Several of the ships carried outstand…
Entities associated with AE Industrial Partners reported the sale of 5,179,743 shares of Redwire Corp common stock for $55,156,790 across transactions on April 16 and April 17, 2026. The sellers retain an indirect stake of 24,238,608 shares. The share sales occurred while Redwire stock trades amid wide volatility and after the company announced a s…
Mary E. Gross, a director at Unity Bancorp Inc. (NASDAQ: UNTY), sold 2,075 shares on April 17, 2026, realizing $116,220 at $56.0101 per share. The transaction comes as the bank's stock trades close to its 52-week high and follows a first-quarter report that modestly exceeded analyst forecasts on both earnings and revenue. Gross retains direct owner…
Liang Yifan, chief financial officer and corporate secretary of Alpha & Omega Semiconductor Ltd (NASDAQ: AOSL), sold 8,625 common shares on April 17, 2026 under a previously established Rule 10b5-1 plan. The transactions totaled $301,878 at prices between $35.0000 and $35.0200 per share, with a weighted average price of $35.0004. The sale occurred …
BridgeBio Oncology Therapeutics (BBOT) shares jumped about 10% in after-hours trading Monday following the U.S. Food and Drug Administration’s Fast Track designation for BBO-11818, a pan-KRAS inhibitor under investigation for advanced KRAS-mutant pancreatic ductal adenocarcinoma. The designation comes after preliminary January 2026 data showing a c…
